1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. BAUSCH + LOMB CORP

Bausch + Lomb Corp

XNYS: BLCO

Mid-range Performer
Download real time

15.45 -0.03 (-0.19%)

28.77% Fall from 52W High

21,694 XNYS Volume

XNYS 19 Mar, 2025 11:36 AM (EDT)

Watchlist

Portfolio

Share
5S
11W
4O
1T
5,445.7

Market Cap

High in industry
-17.2

PE TTM

Negative PE TTM
0.8

PEG TTM

PEG TTM is less than 1
0.8

Price to Book

Below industry Median
0.6

Beta 1Year

Very Low volatility


Insider Trading disclosures for Bausch + Lomb Corp

The latest disclosure was made by Luc Bonnefoy in Bausch + Lomb Corp where a trade of 3,029 Common Shares, No Par Value done at an average price of $16 was reported to US exchanges on Feb. 28, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Luc Bonnefoy President,Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.00 per share. 28 Feb 2025 3,029 74,351 - 16 48,464 Common Shares, No Par Value
Luc Bonnefoy President,Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.00 per share. 28 Feb 2025 1,110 77,380 - 16 17,760 Common Shares, No Par Value
Frederick J. Munsch SVP, Controller and CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 18,581 71,294 - 0 Common Shares, No Par Value
Brenton L. Saunders Director, CEO and Chairman of the Board Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 600,858 600,858 - - Non-Qualified Stock Options (right to purchase)
Brenton L. Saunders Director, CEO and Chairman of the Board Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 168,168 697,156 - 0 Common Shares, No Par Value
Sam A. Eldessouky EVP and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 141,630 141,630 - - Non-Qualified Stock Options (right to purchase)
Sam A. Eldessouky EVP and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 59,459 282,295 - 0 Common Shares, No Par Value
Yehia Hashad EVP of R&D and CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 60,085 60,085 - - Non-Qualified Stock Options (right to purchase)
Yehia Hashad EVP of R&D and CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 25,225 119,580 - 0 Common Shares, No Par Value
Andrew J. Stewart See remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 23,423 66,884 - 0 Common Shares, No Par Value
Andrew J. Stewart See remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 55,793 55,793 - - Non-Qualified Stock Options (right to purchase)
Luc Bonnefoy President,Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 55,793 55,793 - - Non-Qualified Stock Options (right to purchase)
Luc Bonnefoy President,Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2025 23,423 78,490 - 0 Common Shares, No Par Value
Frederick J. Munsch SVP, Controller and CAO Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.83 per share. 23 Dec 2024 2,192 52,713 - 17.8 39,083 Common Shares, No Par Value
Saunders L. Brenton Director, CEO and Chairman of the Board Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.83 per share. 23 Dec 2024 73,782 553,637 - 17.8 1,315,533 Common Shares, No Par Value
Hashad Yehia EVP of R&D and CMO Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.83 per share. 23 Dec 2024 2,751 94,355 - 17.8 49,050 Common Shares, No Par Value
Frederick Munsch J. SVP, Controller and CAO Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.83 per share. 23 Dec 2024 908 54,905 - 17.8 16,190 Common Shares, No Par Value
A. Eldessouky Sam EVP and CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.83 per share. 23 Dec 2024 8,582 222,836 - 17.8 153,017 Common Shares, No Par Value
Yehia Hashad EVP of R&D and CMO Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.83 per share. 23 Dec 2024 2,324 97,106 - 17.8 41,437 Common Shares, No Par Value
Saunders Brenton L. Director, CEO and Chairman of the Board Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.83 per share. 23 Dec 2024 24,649 528,988 - 17.8 439,492 Common Shares, No Par Value
Stewart Andrew J. See remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.83 per share. 23 Dec 2024 2,524 43,461 - 17.8 45,003 Common Shares, No Par Value
Sam A. Eldessouky EVP and CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.83 per share. 23 Dec 2024 7,249 231,418 - 17.8 129,250 Common Shares, No Par Value
John A. Paulson Director Grant, award, or other acquisition of securities at price $ 19.29 per share. 30 Sep 2024 1,134 48,874 - 19.3 21,875 Common Shares, No Par Value
Russel C. Robertson Director Grant, award, or other acquisition of securities at price $ 19.29 per share. 30 Sep 2024 1,328 43,694 - 19.3 25,617 Common Shares, No Par Value
Brenton L. Saunders Director, CEO and Chairman of the Board Purchase of securities on an exchange or from another person at price $ 15.66 per share. 05 Aug 2024 32,250 595,169 - 15.7 505,067 Common Shares, No Par Value
Brenton L. Saunders Director, CEO and Chairman of the Board Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Aug 2024 32,250 627,419 - 0 Common Shares, No Par Value
Sarah B. Kavanagh Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2024 14,696 33,361 - 0 Common Shares, No Par Value
Nathalie Bernier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2024 14,696 49,325 - 0 Common Shares, No Par Value
John A. Paulson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2024 14,696 47,740 - 0 Common Shares, No Par Value
Thomas W. Ross Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2024 14,696 40,053 - 0 Common Shares, No Par Value
Karen L. Ling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2024 14,696 17,338 - 0 Common Shares, No Par Value
Andrew C. von Eschenbach Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2024 14,696 40,053 - 0 Common Shares, No Par Value
Russel C. Robertson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2024 14,696 42,366 - 0 Common Shares, No Par Value
Brett M. Icahn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2024 14,696 40,809 - 0 Common Shares, No Par Value
Sam A. Eldessouky EVP and CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.53 per share. 25 Jul 2024 5,113 238,667 - 15.5 79,405 Common Shares, No Par Value
Frederick J. Munsch SVP, Controller and CAO Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.53 per share. 25 Jul 2024 1,313 55,813 - 15.5 20,391 Common Shares, No Par Value
Yehia Hashad EVP of R&D and CMO Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.53 per share. 25 Jul 2024 2,841 99,430 - 15.5 44,121 Common Shares, No Par Value
Luc Bonnefoy President,Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.53 per share. 25 Jul 2024 2,144 55,067 - 15.5 33,296 Common Shares, No Par Value
John A. Paulson Director Grant, award, or other acquisition of securities at price $ 14.52 per share. 28 Jun 2024 1,506 33,044 - 14.5 21,867 Common Shares, No Par Value
Russel C. Robertson Director Grant, award, or other acquisition of securities at price $ 14.52 per share. 28 Jun 2024 1,764 27,670 - 14.5 25,613 Common Shares, No Par Value
Luc Bonnefoy President,Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.09 per share. 14 Jun 2024 958 57,211 - 15.1 14,456 Common Shares, No Par Value
Andrew J. Stewart See remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.90 per share. 24 Apr 2024 3,943 45,985 - 14.9 58,751 Common Shares, No Par Value
Russel C. Robertson Director Grant, award, or other acquisition of securities at price $ 17.30 per share. 29 Mar 2024 1,481 25,906 - 17.3 25,621 Common Shares, No Par Value
John A. Paulson Director Grant, award, or other acquisition of securities at price $ 17.30 per share. 29 Mar 2024 1,264 31,538 - 17.3 21,867 Common Shares, No Par Value
Karen L. Ling Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Mar 2024 2,642 2,642 - 0 Common Shares, No Par Value
Luc Bonnefoy President,Surgical Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.47 per share. 01 Mar 2024 1,098 58,169 - 16.5 18,084 Common Shares, No Par Value
Sam A. Eldessouky EVP and CFO Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.47 per share. 01 Mar 2024 4,854 243,780 - 16.5 79,945 Common Shares, No Par Value
Frederick J. Munsch SVP, Controller and CAO Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.47 per share. 01 Mar 2024 995 57,126 - 16.5 16,388 Common Shares, No Par Value
Yehia Hashad EVP of R&D and CMO Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.47 per share. 01 Mar 2024 2,143 102,271 - 16.5 35,295 Common Shares, No Par Value
Luc Bonnefoy President,Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2024 50,813 50,813 - - Non-Qualified Stock Options (right to purchase)
Luc Bonnefoy President,Surgical Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2024 16,778 59,267 - 0 Common Shares, No Par Value
Andrew J. Stewart See remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2024 16,778 49,928 - 0 Common Shares, No Par Value
Andrew J. Stewart See remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2024 50,813 50,813 - - Non-Qualified Stock Options (right to purchase)
Yehia Hashad EVP of R&D and CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2024 63,516 63,516 - - Non-Qualified Stock Options (right to purchase)
Yehia Hashad EVP of R&D and CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2024 20,973 104,414 - 0 Common Shares, No Par Value
Frederick J. Munsch SVP, Controller and CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2024 18,183 58,121 - 0 Common Shares, No Par Value
L. Brenton Saunders Director, CEO and Chair Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2024 187,919 562,919 - 0 Common Shares, No Par Value
Eldessouky Sam A. EVP and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2024 50,335 248,634 - 0 Common Shares, No Par Value
Saunders Brenton L. Director, CEO and Chair Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2024 569,105 569,105 - - Non-Qualified Stock Options (right to purchase)
Sam A. Eldessouky EVP and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Feb 2024 152,439 152,439 - - Non-Qualified Stock Options (right to purchase)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters